The first seven of 13 forums in this year’s program will be held today. An afternoon session will focus on trust in science, followed by six concurrent sessions this evening. AACR Meeting News has a preview of all seven.
AACR President David A. Tuveson, MD, PhD, FAACR, uses Wayne Gretzky’s predictive approach to playing hockey as an example for how the cancer community could meet President Biden’s goal of reducing cancer mortality by 50 percent in the next 25 years.
Camille C. R. Ragin, PhD, MPH, led a Saturday afternoon Educational Session that examined how implementation science can be leveraged to address problems that have contributed to health inequities in cancer research and care in the U.S. and abroad.
Three researchers, including session chair Kathy McCoy, PhD, discussed the links between dietary modification of the microbiome and response to immunotherapy during a Friday afternoon Educational Session.
The quest to overcome drug resistance is inextricably linked to Joseph R. Bertino, MD, FAACR, who helped define the mechanisms of action and resistance to one of the most important cancer chemotherapy agents, methotrexate.
Catriona H. M. Jamieson, MD, PhD, previews the Precancer Discover Science plenary, which examined new perspectives on cancer prevention, an integral part of the AACR’s research and health policy efforts.
The Opening Plenary Session reflects the meeting’s theme by showcasing several examples of how researchers are decoding the complexities of cancer, said Program Committee Chair Marcia R. Cruz-Correa, MD, PhD.